Article

TB4 can protect cornea against oxidative damage

Administering TB4 (Thymosin Beta 4, RegeneRx) up-regulates anti-oxidative enzymes in human corneal epithelial cells, helping to protect the cornea and resist oxidative damage, according to researchers.

Bethesda, MD-Administering TB4 (Thymosin Beta 4, RegeneRx) up-regulates anti-oxidative enzymes in human corneal epithelial cells, helping to protect the cornea and resist oxidative damage, according to a study done by researchers at the Institute of Biopharmaceutical Science, National Yang-Ming University, Tapei, Taiwan.

The researchers believe that TB4's ability to protect cells against oxidative damage is due to cellular internalization, or the ability to migrate inside cells, which they said is essential for TB4's protective effects.

"This interesting study from an independent research group in Taiwan further expands the research we and others have conducted and shows yet again TB4's effects in protecting and repairing tissues-in this case the cornea," said Gabriel Sosne, MD, PhD, assistant professor of ophthalmology at Wayne State University School of Medicine and the Kresge Eye Institute in Detroit, and a member of the RegeneRx Medical and Scientific Advisory Board.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.